PLEASANTON, Calif., June 20, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has started shipping its new Xenium Prime 5K ...
PLEASANTON, Calif., March 21, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Xenium multi-modal ...
In the September 9 cover article of Cancer Cell, researchers integrated 10x single cell and spatial technologies to identify a mechanism of glioblastoma recurrence in mice and develop a promising ...
Citi analyst Patrick B Donnelly has maintained their bullish stance on TXG stock, giving a Buy rating today. Patrick B Donnelly has given his Buy rating due to a combination of factors. In 3Q23, 10x ...
PLEASANTON, Calif., Dec. 20, 2023 /PRNewswire/ -- 10x Genomics, Inc., (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of its Xenium Catalyst Network, a global ...
Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region ASTRA will bring together molecular and spatial data ...
ROCKVILLE, Md., Sept. 12, 2023 /PRNewswire/ -- Multiomics CRO Psomagen is thrilled to announce the launch of Spatial Biology services for 10X Genomics Xenium™. This platform is reshaping spatial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results